Univest
Univest
  • Markets

3 Diagnostics Kits Maker, Specialty Chemicals Maker and Ethnic Foods Exporter Stocks With a Strong Future Roadmap: Molbio Diagnostics, Vishnu Chemicals and ADF Foods

  • November 18, 2026
  • Posted by: Ankit Jaiswal
  • Category: Best Stocks
No Comments
3 Diagnostics Kits Maker, Specialty Chemicals Maker and Ethnic Foods Exporter Stocks With a Strong Future Roadmap: Molbio Diagnostics, Vishnu Chemicals and ADF Foods

Molbio Diagnostics, Vishnu Chemicals and ADF Foods: ROE of 13.3% to 15.7% and FY22 to FY26 revenue CAGR of 10.9% to 16.8%. Prices as of 17 Nov 2026.

Quick Answer

The three diagnostic kit, chemical and pickle stocks to watch are Molbio Diagnostics, Vishnu Chemicals and ADF Foods. Their return on equity ranges from 13.3% to 15.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 10.9% to 16.8%. ADF Foods has the highest return on equity at 15.7%, while Molbio Diagnostics has the fastest revenue growth at 16.8% a year. Prices are based on the 17 November 2026 close, and this article is educational, not investment advice.

Diagnostic kit, chemical and pickle stocks offer a focused view of a sector where demand keeps widening. Molbio Diagnostics, Vishnu Chemicals and ADF Foods cover a diagnostics kits maker, a specialty chemicals maker and an ethnic foods exporter.

This list covers three diagnostic kit, chemical and pickle stocks with complete current figures: Molbio Diagnostics, Vishnu Chemicals and ADF Foods. Every figure comes from the latest reported financials and the 17 November 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • What Are Diagnostic Kit, Chemical and Pickle Stocks?
  • Diagnostic Kit, Chemical and Pickle Stocks at a Glance
  • Why Do Diagnostic Kit, Chemical and Pickle Stocks Have a Strong Roadmap in India?
  • Why Molbio Diagnostics Features Among These Diagnostic Kit, Chemical and Pickle Stocks
  • Why Vishnu Chemicals Features Among These Diagnostic Kit, Chemical and Pickle Stocks
  • Why ADF Foods Features Among These Diagnostic Kit, Chemical and Pickle Stocks
  • Molbio Diagnostics vs Vishnu Chemicals vs ADF Foods on Key Financials
  • Key Risks to Check Before Investing in Diagnostic Kit, Chemical and Pickle Stocks
  • Final Thoughts on Diagnostic Kit, Chemical and Pickle Stocks
    • What are diagnostic kit, chemical and pickle stocks?
    • Which diagnostic kit, chemical and pickle stocks are covered in this list?
    • Why do diagnostic kit, chemical and pickle stocks have a strong future roadmap in India?
    • How has Molbio Diagnostics performed financially?
    • How has Vishnu Chemicals performed financially?
    • How has ADF Foods performed financially?
    • What risks should investors check before buying diagnostic kit, chemical and pickle stocks?
    • Is this list of diagnostic kit, chemical and pickle stocks investment advice?

What Are Diagnostic Kit, Chemical and Pickle Stocks?

Diagnostic kit, chemical and pickle stocks are listed companies that make molecular diagnostic kits and tests, make specialty chemicals for industry and batteries, and make and export ethnic foods, pickles and ready meals. Their earnings depend on test kit demand, chemical orders and export food demand.

Diagnostic Kit, Chemical and Pickle Stocks at a Glance

Company CMP (Rs) Market Cap (Rs Cr) P/E Industry P/E ROE (%) D/E
Molbio Diagnostics 1,484.1 16,605 101.2 59.6 14.2 0.38
Vishnu Chemicals 549.9 3,788 25.3 33.2 13.3 0.49
ADF Foods 240.45 2,900 31.5 33.9 15.7 0.02

On valuation, Vishnu Chemicals and ADF Foods trade at a P/E below the industry P/E, while Molbio Diagnostics trades above it, which reflects the growth the market already expects. Readers comparing diagnostic kit, chemical and pickle stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.

Why Do Diagnostic Kit, Chemical and Pickle Stocks Have a Strong Roadmap in India?

Diagnostic kit, chemical and pickle stocks have a strong roadmap in India because wider use of molecular testing, rising demand for specialty chemicals and growing demand for ethnic foods abroad keep widening the market for these companies.

  • Diagnostic kits. Clinics need accurate test kits.
  • Specialty chemicals. Industry needs tailored inputs.
  • Ethnic foods. Overseas shoppers buy Indian foods.

Why Molbio Diagnostics Features Among These Diagnostic Kit, Chemical and Pickle Stocks

Among the diagnostic kit, chemical and pickle stocks on this list, Molbio Diagnostics, based in Goa, develops the Truenat platform, a portable molecular diagnostics system that delivers lab-grade PCR results at the point of care, with strong use in tuberculosis testing.

The company has a return on equity of 14.2%, a debt to equity ratio of 0.38 and a market capitalisation of Rs 16,605 crore. The stock trades at a P/E of 101.2, above the industry P/E of 59.6.

Revenue rose from Rs 782 crore in FY22 to Rs 1,455 crore in FY26, a compound annual growth rate of 16.8%. Net profit grew from Rs 83.5 crore in FY24 to Rs 164 crore in FY26, which works out to a compound annual growth rate of 40.2%.

Roadmap: Its roadmap centres on widening the Truenat test menu beyond TB, pushing into more countries through government and donor programmes, and building recurring revenue from test chips and consumables on top of the installed analyser base.

What to watch: Order timing from public health programmes can be lumpy, so look at annual rather than single-quarter trends.

Why Vishnu Chemicals Features Among These Diagnostic Kit, Chemical and Pickle Stocks

Among the molecular tests, specialty inputs and ethnic food shares on this list, Vishnu Chemicals is a Hyderabad-based specialty chemicals maker that produces chromium and barium compounds used in leather, pigments, cement and industrial applications for customers in India and abroad.

Revenue rose from Rs 1,075 crore in FY22 to Rs 1,626 crore in FY26, a compound annual growth rate of 10.9%. Net profit grew from Rs 81.4 crore in FY22 to Rs 142 crore in FY26, which works out to a compound annual growth rate of 15.0%.

In the June 2026 quarter, revenue grew 26.9% year on year to Rs 446 crore, while net profit rose 23.0% to Rs 39.6 crore. The company has a return on equity of 13.3%, a debt to equity ratio of 0.49 and a market capitalisation of Rs 3,788 crore. The stock trades at a P/E of 25.3, below the industry P/E of 33.2.

Roadmap: The company is expanding capacity for chromium chemicals and moving into higher-value products, which supports export demand. Its position in a niche segment with few producers helps it hold pricing.

What to watch: Track export demand, capacity additions and raw material costs.

Why ADF Foods Features Among These Diagnostic Kit, Chemical and Pickle Stocks

Among the three companies on this list, ADF Foods, based in Gujarat, makes ready-to-eat Indian meals, sauces, pickles and frozen foods, and sells brands such as Ashoka and Camel in India and overseas.

In the June 2026 quarter, revenue grew 23.9% year on year to Rs 168 crore, while net profit rose 13.5% to Rs 17.3 crore. Revenue rose from Rs 431 crore in FY22 to Rs 703 crore in FY26, a compound annual growth rate of 13.0%.

Net profit grew from Rs 48.5 crore in FY22 to Rs 89.9 crore in FY26, which works out to a compound annual growth rate of 16.7%. The company has a return on equity of 15.7%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 2,900 crore. The stock trades at a P/E of 31.5, below the industry P/E of 33.9.

Roadmap: Indian food demand abroad, driven by the diaspora and global interest in ethnic cuisine, supports its exports. The company is also growing its domestic brand presence and its ready-to-eat range.

What to watch: Monitor shipping costs and export demand in its main markets.

Molbio Diagnostics vs Vishnu Chemicals vs ADF Foods on Key Financials

The table below sets the three diagnostic kit, chemical and pickle stocks side by side on revenue, profit and margin, using reported figures.

Company FY22 Revenue (Rs Cr) FY26 Revenue (Rs Cr) Revenue CAGR (FY22-FY26) FY26 Net Profit (Rs Cr) FY26 Net Margin
Molbio Diagnostics 782 1,455 16.8% 164 11.3%
Vishnu Chemicals 1,075 1,626 10.9% 142 8.8%
ADF Foods 431 703 13.0% 89.9 12.8%

ADF Foods posts the highest return on equity in this group at 15.7%. Vishnu Chemicals has the largest FY26 revenue at Rs 1,626 crore, and Molbio Diagnostics shows the fastest revenue growth with a 16.8% compound annual rate. A useful habit with diagnostic kit, chemical and pickle stocks is to check each new quarterly result against the capacity plans the company described earlier.

Key Risks to Check Before Investing in Diagnostic Kit, Chemical and Pickle Stocks

Every theme carries risks that deserve a check before any decision. For these diagnostic kit, chemical and pickle stocks, the main points are: Long-term molecular tests, specialty inputs and ethnic food shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.

  • Regulatory approvals. Plant inspections and approvals can affect supplies.
  • Raw material and energy costs. Input prices can move margins in chemicals.
  • Currency moves. Export earnings move with the rupee.

Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.

Use the Univest Stock Screener to filter diagnostic kit, chemical and pickle stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.

Final Thoughts on Diagnostic Kit, Chemical and Pickle Stocks

Diagnostic kit, chemical and pickle stocks reward patient research into demand, execution and financial strength. Molbio Diagnostics, Vishnu Chemicals and ADF Foods each have a clear plan to grow. Based on the 17 November 2026 close, Molbio Diagnostics trades at Rs 1,484.1, Vishnu Chemicals at Rs 549.9 and ADF Foods at Rs 240.45.

Download the Univest iOS App or Univest Android App to track diagnostic kit, chemical and pickle stocks, set price alerts and get research-backed stock ideas.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

What are diagnostic kit, chemical and pickle stocks?

Ans. Diagnostic kit, chemical and pickle stocks are listed companies that make molecular diagnostic kits and tests, make specialty chemicals for industry and batteries, and make and export ethnic foods, pickles and ready meals. Their earnings depend on test kit demand, chemical orders and export food demand. This list looks at three of them, Molbio Diagnostics, Vishnu Chemicals and ADF Foods, using reported FY22 to FY26 financials and the 17 November 2026 closing prices.

Which diagnostic kit, chemical and pickle stocks are covered in this list?

Ans. This list covers Molbio Diagnostics, Vishnu Chemicals and ADF Foods. Based on the 17 November 2026 close, Molbio Diagnostics traded at Rs 1,484.1, Vishnu Chemicals at Rs 549.9 and ADF Foods at Rs 240.45. Their return on equity ranges from 13.3% to 15.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 10.9% to 16.8%.

Why do diagnostic kit, chemical and pickle stocks have a strong future roadmap in India?

Ans. Diagnostic kit, chemical and pickle stocks have a strong roadmap in India because wider use of molecular testing, rising demand for specialty chemicals and growing demand for ethnic foods abroad keep widening the market for these companies. The main drivers are as follows. Diagnostic kits. Clinics need accurate test kits. Specialty chemicals. Industry needs tailored inputs. Ethnic foods. Overseas shoppers buy Indian foods. Together these factors give the companies on this list a visible path for growth over the coming years.

How has Molbio Diagnostics performed financially?

Ans. Revenue rose from Rs 782 crore in FY22 to Rs 1,455 crore in FY26, a compound annual growth rate of 16.8%. Net profit grew from Rs 83.5 crore in FY24 to Rs 164 crore in FY26, which works out to a compound annual growth rate of 40.2%. The company has a return on equity of 14.2%, a debt to equity ratio of 0.38 and a market capitalisation of Rs 16,605 crore. The stock trades at a P/E of 101.2, above the industry P/E of 59.6. Looking ahead, its roadmap centres on widening the Truenat test menu beyond TB, pushing into more countries through government and donor programmes, and building recurring revenue from test chips and consumables on top of the installed analyser base.

How has Vishnu Chemicals performed financially?

Ans. Revenue rose from Rs 1,075 crore in FY22 to Rs 1,626 crore in FY26, a compound annual growth rate of 10.9%. Net profit grew from Rs 81.4 crore in FY22 to Rs 142 crore in FY26, which works out to a compound annual growth rate of 15.0%. In the June 2026 quarter, revenue grew 26.9% year on year to Rs 446 crore, while net profit rose 23.0% to Rs 39.6 crore. The company has a return on equity of 13.3%, a debt to equity ratio of 0.49 and a market capitalisation of Rs 3,788 crore. The stock trades at a P/E of 25.3, below the industry P/E of 33.2. Looking ahead, the company is expanding capacity for chromium chemicals and moving into higher-value products, which supports export demand. Its position in a niche segment with few producers helps it hold pricing.

How has ADF Foods performed financially?

Ans. Revenue rose from Rs 431 crore in FY22 to Rs 703 crore in FY26, a compound annual growth rate of 13.0%. Net profit grew from Rs 48.5 crore in FY22 to Rs 89.9 crore in FY26, which works out to a compound annual growth rate of 16.7%. In the June 2026 quarter, revenue grew 23.9% year on year to Rs 168 crore, while net profit rose 13.5% to Rs 17.3 crore. The company has a return on equity of 15.7%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 2,900 crore. The stock trades at a P/E of 31.5, below the industry P/E of 33.9. Looking ahead, indian food demand abroad, driven by the diaspora and global interest in ethnic cuisine, supports its exports. The company is also growing its domestic brand presence and its ready-to-eat range.

What risks should investors check before buying diagnostic kit, chemical and pickle stocks?

Ans. Investors should check a few risks before buying diagnostic kit, chemical and pickle stocks. Regulatory approvals. Plant inspections and approvals can affect supplies. Raw material and energy costs. Input prices can move margins in chemicals. Currency moves. Export earnings move with the rupee. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.

Is this list of diagnostic kit, chemical and pickle stocks investment advice?

Ans. No. This article is educational and uses publicly available data as of the 17 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.



ADF Foods battery chemicals and packaged foods stocks Best Stocks chemical and pickle stocks diagnostic kit Molbio Diagnostics molecular tests PCR kits specialty inputs and ethnic food shares Vishnu Chemicals
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply